More than 300 attendees came together to celebrate the academic success of graduating students and to honor faculty and staff ...

The company has increased manufacturing capacity from pilot scale to 1 million liters annually, and can now assist customers ...

VERAXA Biotech AG, a developer of innovative cancer therapies, has announced a partnership with OmniAb, Inc. to create a bispecific antibody drug conjugate (bsADC) program aimed at treating solid ...

This press release contains forward-looking statements, which are based on current views, expectations and projections of the management of Marinomed Biotech AG about future events. These forward ...